MiNK Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
LONGBOW FINANCE SA | 05/07/2025 | 16.67 K | $144.00 K | -90.00% | 0.04% |
JPMORGAN CHASE & CO | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
NORTHERN TRUST CORP | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
STATE STREET CORP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
VANGUARD GROUP INC | 05/09/2025 | 0 | $0 | -100.00% | 0.00% |
FMR LLC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
MORGAN STANLEY | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
GREENWICH WEALTH MANAGEMENT LLC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
HIGHTOWER ADVISORS, LLC | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
ALLWORTH FINANCIAL LP | 04/30/2025 | 0 | $0 | -100.00% | 0.00% |
UBS GROUP AG | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
KEY FINANCIAL INC | 05/01/2025 | 0 | $0 | -100.00% | 0.00% |
GAME PLAN FINANCIAL ADVISORS, LLC | 05/19/2025 | 0 | $0 | -100.00% | 0.00% |
COVESTOR LTD | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
BLACKROCK, INC. | 05/02/2025 | 0 | $0 | -100.00% | 0.00% |
MiNK Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 27 institutional investors and hedge funds held shares of MiNK Therapeutics, Inc.. The most heavily invested institutionals were:
Longbow Finance SA: 16,667
STATE STREET CORP: 0
BNP PARIBAS ARBITRAGE, SNC: 0
WELLS FARGO & COMPANY/MN: 0
Key FInancial Inc: 0
MORGAN STANLEY: 0
0.04% of MiNK Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 106.22 K shares in the last 24 months. This purchase volume represents approximately $2.13 M in transactions.